Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre of Marseille (CRCM), shared a post on LinkedIn:
“Honored to have been invited to the International Biotherapy Days in Toulouse.
I had the pleasure to present PANCProfiler, an integrative framework combining single-cell transcriptomics and patient-derived preclinical models to decipher therapeutic resistance programs in pancreatic cancer.
What makes this meeting particularly valuable is the way it brings together academic research, clinical perspectives, and innovation ecosystems, creating a space where mechanistic insights can naturally resonate beyond the laboratory.
Many thanks to the organizing committee for this invitation and the quality of the discussions, and special thanks to my friend Pierre Cordelier for making this possible.”
More posts featuring Nelson Dusetti on OncoDaily.